Four things you need to know about Medicare drug costs and coverage in 2025
With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the ...
Targeted Oncology1d
FDA Clears Investigational New Drug Application for CD-001 in Oncology
Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.
fbcnews1h
Strategy targets drug issues
The Fiji Police Force is prioritizing efforts to enhance its responsiveness, particularly in law enforcement and drug control ...
9 Major Medicare Changes for 2025 and How They'll Impact Your Coverage
Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes ...
Cure Today13d
FDA OKed New Drug Application for Novel Glioblastoma Treatment
The Food and Drug Administration (FDA) has cleared an investigational new drug application for the novel treatment, APTN-101, ...
FierceBiotech3d
FDA scraps adcomm for Applied's rare disease drug ahead of November decision
adaptive behavior and tremor” and went ahead with filing a new drug application with the FDA. Applied had planned to ask for U.S. approval on the strength of biomarker data, only for the FDA to ...
Applied Therapeutics: AdCom Decision Takes Govorestat Approval A Step Closer
Stock of Applied Therapeutics, Inc. surges as FDA skips AdCom for AT-007 in galactosemia. Read more on recent developments ...
An appeals court has revived a challenge to President Biden's Medicare drug price reduction program
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...
Challenge to US drug price negotiation program revived by appeals court
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
Marketplace1d
Generic drugs in the U.S. face new economic pressures 40 years on
The generic drug industry in the U.S. has saved people billions of dollars, but shortages are now the norm and competition is ...
Business Wire2d
Cybin Provides Corporate Update on Upcoming Clinical Milestones
CYB004 Phase 2 Program Outline Dr. Atul R. Mahableshwarkar M.D., DLFAPA ... Dr. Macek brings decades of pharmaceutical industry experience in new drug development across all phases of research ...
Appeals court revives challenge to Biden’s Medicare drug price reduction program
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for widely used ...